Interactive Series

Challenges and Opportunities in HIV

Practical Solutions Across the Spectrum of Care

Clinical Practice Guidelines

Primary care guidelines for the management of persons infected with HIV: 2013 update by the HIV Medicine Association of the Infectious Diseases Society of America.

Aberg JA, Gallant JE, Ghanem KG, Emmanuel P, Zingman BS, Horberg MA. Clin Infect Dis. 2014;58(1):e1-e34.

Recommendations for evaluation and management of bone disease in HIV.

Brown TT, Hoy J, Borderi M, et al. Clin Infect Dis. 2015;60(8):1242-1251.

Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2020 recommendations of the International Antiviral Society-USA Panel.

Saag M, Gandhi R, Hoy J, et al.JAMA. 2020. [Epub ahead of print].

Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline.

Stevens PE, Levin A. Ann Intern Med. 2013;158(11):825-830.

Guidelines for the use of antiretroviral agents in adults and adolescents living with HIV.

US Department of Health and Human Services

Recommendations for the use of antiretroviral drugs in pregnant women with HIV infection and interventions to reduce perinatal HIV transmission in the United States.

US Department of Health and Human Services

Guidelines for Managing Advanced HIV Disease and Rapid Initiation of Antiretroviral Therapy.

World Health Organization

Clinician Resources

Atherosclerotic cardiovascular disease (ASCVD) Risk Estimator Plus

American College of Cardiology, American Heart Association.

Glomerular filtration rate (GFR) calculator

National Kidney Foundation.

Patient Health Questionnaire-2 (PHQ-2)

National HIV Curriculum

Patient and Caregiver Resources

AIDSMap resources

NAM Publications

Resources for persons living with HIV

Centers for Disease Control and Prevention

How to quit smoking

Centers for Disease Control and Prevention

HIV resources

National Institutes of Health

Suggested Readings

Preventing HIV infection in women: a global health imperative.

Abdool Karim Q, Sibeko S, Baxter C. Clin Infect Dis. 2010;50(suppl 3):S122-S129.

Brief report: randomized, double-blind comparison of tenofovir alafenamide (TAF) vs tenofovir disoproxil fumarate (TDF), each coformulated with elvitegravir, cobicistat, and emtricitabine (E/C/F) for initial HIV-1 treatment: week 144 results.

Arribas JR, Thompson M, Sax PE, et al. J Acquir Immune Defic Syndr. 2017;75(2):211-218.

Improving care outcomes for PLWH experiencing homelessness and unstable housing: a synthetic review of clinic-based strategies.

Clemenzi-Allen AA, Hickey M, Conte M, et al. Curr HIV/AIDS Rep. 2020;17(3):259-267.

Rapid antiretroviral therapy: time for a new standard of care.

Coffey S, Halperin J, Rana AI, Colasanti JA. Clin Infect Dis. 2020. [Epub ahead of print]

U.S. medical eligibility criteria for contraceptive use, 2016.

Curtis KM, Tepper NK, Jatlaoui TC, et al. MMWR Recomm Rep. 2016;65(3):1-103.

Implementation of a rapid entry program decreases time to viral suppression among vulnerable persons living with HIV in the southern United States.

Colasanti J, Sumitani J, Mehta CC, et al. Open Forum Infect Dis. 2018;5(6):ofy104.

HIV viral load and transmissibility of HIV infection: undetectable equals untransmittable.

Eisinger RW, Dieffenbach CW, Fauci AS. JAMA. 2019;321(5):451-452.

Characteristics, prevention, and management of cardiovascular disease in people living with HIV: a scientific statement from the American Heart Association.

Feinstein MJ, Hsue PY, Benjamin LA, et al. Circulation. 2019;140(2):e98-e124.

Linkage and antiretroviral therapy within 72 hours at a Federally Qualified Health Center in New Orleans.

Halperin J, Butler I, Connor K, et al. AIDS Patient Care STDS. 2018;32(2):39-41.

A care continuum of immediate ART for newly diagnosed patients and patients presenting later to care at a Federally Qualified Health Center in New Orleans.

Halperin J, Conner K, Butler I, et al. Open Forum Infect Dis. 2019;6(4):ofz161.

Polypharmacy and drug-drug interactions in older and younger people living with HIV: the POPPY study.

Halloran MO, Boyle C, Kehoe B, et al. Antivir Ther. 2019;24(3):193-201.

Neuropsychiatric adverse events with dolutegravir and other integrase strand transfer inhibitors.

Hoffmann C, Llibre JM. AIDS Rev. 2019;21(1):4-10.

Human immunodeficiency virus and trans women: a literature review.

Jaspal R, Kennedy L, Tariq S. Transgend Health. 2018;3(1):239-250.

The impact of comorbidities, depression, and substance use problems on quality of life among older adults living with HIV.

Millar BM, Starks TJ, Gurung S, Parsons JT. AIDS Behav. 2017;21(6):1684-1690.

Ageing and inflammation in patients with HIV infection.

Nasi M, De Biasi S, Gibellini L, et al. Clin Exp Immunol. 2017;187(1):44-52.

The effect of same-day observed initiation of antiretroviral therapy on HIV viral load and treatment outcomes in a US public health setting.

Pilcher CD, Ospina-Norvell C, Dasgupta A, et al. J Acquir Immune Defic Syndr. 2017;74(1):44-51.

Weight gain following initiation of antiretroviral therapy: risk factors in randomized comparative clinical trials.

Sax PE, Erlandson KM, Lake JE, et al. Clin Infect Dis. 2020;71(6):1379-1389.

Current challenges and solutions in research and clinical care of older persons living with HIV: findings presented at the 9th International Workshop on HIV and Aging.

Sundermann EE, Erlandson KM, Pope CN, et al. AIDS Res Hum Retroviruses. 2019;35(11-12):985-998.

HIV and aging.

Wing EJ. Int J Infect Dis. 2016;53:61-68.

HIV and ischemic heart disease.

Vachiat A, McCutcheon K, Tsabedze N, Zachariah D, Manga P. J Am Coll Cardiol. 2017;69(1):73-82.

Update on neural tube defects with antiretroviral exposure in the Tsepamo study, Botswana.

Zash R, Holmes L, Diseko M, et al. J Int AIDS Soc. 2020;23(suppl 4):183-184. Abstract OAXLB0102.

Relevant Resources

PrEP for Your Patients’ Needs

The PCPs Role in Preventing HIV

Value-Based HIV Formularies

Optimizing Use of Clinical Evidence & Pharmacoeconomic Models in Managed Care

Hepatitis C is Curable

Got it? Treat it!

Real-World Issues in HIV Prevention & Treatment

The Critical Role of the Community Pharmacist


Bringing Local Communities Together to Eliminate Coinfection Through Knowledge and Partnerships.

Evolving Models of HIV Care

Volume 1: Rapid ART Initiation: A New Addition to the HIV-Care Tool Box

Updates in HCV Screening and Treatment

Key Issues Impacting OB/GYN Practice

Clinical Issues in Chronic Liver Disease

Hot Topics in HBV, HCV, and NASH

Evolving Models of HIV Care

Volume II: Expanding Evidence for the Role of Rapid ART Initiation in HIV Practice

Assessing Your Patients for HCV and HIV

Why It Matters in OB/GYN Practice Today

HIV as a Chronic Disease

A Treater’s Guide to Optimizing Care in the Aging Patient with Comorbidities

The Pursuit of Hepatitis C Elimination

How the Pharmacist Can Make a Difference

Trends in Infectious Diseases: Updates on Treatment & Prevention Strategies for HIV and HCV

Understanding the Growing Syndemic — Opioids, HCV, and HIV

Stepping Up to the Challenge

The PCP’s Role in HCV Elimination

The Changing Landscape of HIV Prevention

What the Pharmacist Needs to Know about PrEP

Evolving Models of HIV Care (Volume 3)

The Rapid ART Standard of Care: From Evidence to Healthcare Equity

HIV Updates for Pharmacy Practice

Maximizing Your Role to Impact Patient Outcomes


Building Bridges to Reach People Who Inject Drugs With the Goal to Eliminate HCV

Case Challenges in HIV Medicine

Benefits, Barriers, & Best Practices in an Advancing Field

Expanding HIV Prevention in Colorado—and Nationwide

A PEP/PrEP Training Guide for Pharmacists

Treating Hepatitis C in the Primary Care Setting

A Critical Step Toward HCV Elimination

Honing Clinical Skills in HIV Treatment

Considering the Patient, the Provider, and the Science

Hot Topics in HCV

A Multidisciplinary Online Mini-Curriculum

Clinical Issues in COVID-19

Debates and Discussions about Monoclonal Antibody Therapies

Minimizing Patient Risks From COVID-19

An Update on Monoclonal Antibody Therapies

Treating Hepatitis C in the Primary Care Setting

Establishing Clinical Readiness Through Mentored Learning

Clinical Updates in COVID-19

Recent Developments in Anti-SARS-CoV-2 Monoclonal Antibodies for Treatment

Monoclonal Antibodies for COVID-19

An Update on Best Practices

Monoclonal Antibodies for COVID-19

New Avenues to Pre-Exposure Prophylaxis

Virologic Failure in HIV

An Updated Clinician’s Guide to Assessment and Management

Applying HIV Advances in Practice

What the Pharmacist Needs to Know

Buffing Up on New and Emerging ART

A Look at the Changing HIV Playing Field

Pharmacy PrEP Education

A “How To” Series Spanning Policy to Practice


Building Bridges to Reach People who Inject Drugs with the Goal of Employing PrEP for HIV Prevention

Long-Acting Injectable PrEP:

Bringing HIV Prevention to a New Level

PrEParing to End the Epidemic

Optimizing HIV Prevention in Primary Care

A Call to Action

Monoclonal Antibodies for the Prevention and Treatment of COVID-19

Answers to Everyday Practice Challenges in HIV Medicine

A Phone-a-Friend CME Series – Volume 2

What’s New in the Management of COVID-19

Incorporating New Data and Updated Guidelines Into Daily Practice